Makya, our solution for data-driven de novo drug design

Makya is the first user-friendly SaaS platform for AI-driven de novo drug design focused on Multi-Parametric Optimization (MPO). It assists your chemists into designing novel and easy to make compounds in line with multi-objective blueprint, all with unprecedented speed, performance, and diversity. 

Makya offers multiple generative algorithms covering all aspects of your drug design process, from hit discovery to fragment-based lead design and lead optimisation. Synthetic accessibility prediction is integrated to allow the algorithms to generate creative, yet easily feasible molecules. Moreover, Makya can be coupled with structure-based generative design technologies, unleashing the full power of AI-driven drug design to efficiently navigate the chemical space and find relevant 3D solutions.

Learn more at: https://iktos.ai/solution/makya